J&J ac­quires Cal­i­for­nia med­ical de­vice com­pa­ny for $400M

John­son & John­son put down $400 mil­lion up­front to ac­quire Lam­i­nar, a med­ical de­vice com­pa­ny fo­cused on re­duc­ing the risk of stroke for pa­tients with an ir­reg­u­lar heart­beat.

The deal comes a cou­ple months af­ter John­son & John­son de­buted a new vi­su­al iden­ti­ty fol­low­ing the spin­off of its con­sumer unit Ken­vue, “unit­ing” its medtech and phar­ma­ceu­ti­cal units un­der the par­ent J&J brand. CEO Joaquin Du­a­to called it a “next era” for J&J, in which the two seg­ments are “more con­nect­ed” to the brand.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER